ReviewPharmacoEconomics2021

The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature.

Boshen Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.